A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration

Clinical trial NCT00395057 · TERMINATED

Trial details

NCT number: NCT00395057
Sponsor: Allergan
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Choroid Neovascularization Age-Related Macular Degeneration

Start date: 2007-01-01
Primary completion: 2008-10-01
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.